Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 45 Breast Neoplasms 20 Myelodysplastic Syndromes 19 Prostatic Neoplasms 12 Neoplasms 12 Leukemia, Myelomonocytic, Chronic 12 Carcinoma, Hepatocellular 10 Stomach Neoplasms 9 Recurrence 9 Carcinoma, Non-Small-Cell Lung 8 Neoplasm Metastasis 7 Esophageal Neoplasms 7 Uterine Cervical Neoplasms 6 Sarcoma 6 Ovarian Neoplasms 6 Multiple Myeloma 6 Lung Neoplasms 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Myeloproliferative Disorders 5 Melanoma 5 Lymphoma, Non-Hodgkin 5 Lymphoma, B-Cell 5 Esophageal Squamous Cell Carcinoma 5 Colorectal Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Pancreatic Neoplasms 4 Myelodysplastic-Myeloproliferative Diseases 4 Leukemia, Biphenotypic, Acute 4 Cholangiocarcinoma 4 Thrombocythemia, Essential 3

Interventions

Insulin Glargine 4 Insulin 3 volagidemab 2 Metformin 2 Alpelisib 2 ziprasidone 1 olaparib 1 exemestane 1 Vildagliptin 1 Tamoxifen 1 Standard of Care 1 Olanzapine 1 Letrozole 1 Insulin Lispro 1 Insulin Aspart 1 Injections 1 Fulvestrant 1 DNA, Ribosomal 1 Control Groups 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hyperglycemia × Injections × Clear all

NCT02216799 2016-02-25

GLUCOSE-in-PN

King Faisal Specialist Hospital & Research Center

Phase 4 Completed

Hyperglycemia, Hyperphagia, Insulin Resistance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡